Acumen Hypotension Prediction Index – EV1000 Clinical Platform vs Rhythm360

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by RhythmScience

AI Verdict

Tool A is designed for real-time prediction and management of acute hypotensive events in critical care and surgical settings, integrating with specific monitoring platforms. Tool B is a broader, cloud-based platform for aggregating and analyzing cardiac monitoring data from various devices, focusing on hypertension, heart failure, and rhythm management, with features for clinic workflow and billing. While both operate in cardiology, Tool A targets acute, immediate intervention, whereas Tool B focuses on comprehensive, longitudinal cardiac care management and operational efficiency.

Choose Acumen Hypotension Prediction Index – EV1000 Clinical Platform if…

Choose Acumen Hypotension Prediction Index if your primary need is real-time, proactive management of hemodynamic instability in acute care settings like the operating room or ICU. This tool is ideal for clinicians who require early warnings of hypotensive events and actionable insights into their potential causes to intervene before a crisis. It integrates directly with existing Edwards Lifesciences monitoring platforms for continuous, immediate patient assessment.

View Acumen Hypotension Prediction Index – EV1000 Clinical Platform →

Choose Rhythm360 if…

Choose Rhythm360 if your cardiology practice requires a comprehensive, vendor-neutral platform to aggregate and analyze cardiac monitoring data from diverse devices. This solution is best suited for clinics aiming to streamline remote patient monitoring, reduce alert fatigue through AI-driven triage, and automate billing for chronic conditions like hypertension and heart failure. It offers robust EHR integration and optional technician oversight for efficient long-term patient management.

View Rhythm360 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Rhythm360
Pricing Unknown Flexible pricing model that scales with clinic size and platform usage.
Deployment On-premise (integrated with EV1000 clinical platform and HemoSphere advanced monitoring platform) Cloud-based SaaS platform
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Unknown
HIPAA Yes AI-estimated Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Rhythm360
Name Acumen Hypotension Prediction Index u2013 EV1000 Clinical Platform Rhythm360
Company Edwards Lifesciences RhythmScience
Tagline Predicting and managing hypotension before it occurs. Revolutionizing cardiac care with RhythmScience: The most comprehensive platform for cardiology.
Primary Clinical Focus Predicts hypotensive events and provides insights into hemodynamic instability to help reduce intraoperative hypotension. Unifies cardiac monitoring data, providing actionable insights for hypertension, heart failure, and rhythm management.
Core AI Functionality Machine learning-based algorithm for predicting hypotension up to 15 minutes in advance. AI-driven alert triage (reduces alert fatigue) and AI Data Normalization.
Specialties Anesthesiology, Critical Care, Emergency Medicine Cardiology

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform and Rhythm360.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Acumen HPI is designed for acute care settings like anesthesiology, critical care, and emergency medicine, focusing on real-time prediction and management of intraoperative hypotension. Rhythm360 is tailored for cardiology practices, unifying data from various cardiac monitoring devices to manage hypertension, heart failure, and arrhythmias in a more chronic care context.
Acumen HPI integrates directly with Edwards Lifesciences' monitoring platforms, requiring dedicated sensors for continuous hemodynamic data collection in acute settings. Rhythm360 offers vendor-neutral data aggregation from all major cardiac device OEMs and provides bi-directional EHR integration, streamlining data from diverse sources into a unified platform for chronic cardiac care.
Acumen HPI provides a Hypotension Prediction Index score, Smart Alerts, and detailed hemodynamic insights (preload, afterload, contractility) to guide immediate intervention for hypotension. Rhythm360 uses AI-driven alert triage to significantly reduce alert fatigue and offers predictive algorithms for heart failure management, optimizing responses across a broader range of cardiac conditions.
Acumen HPI integrates into an existing Edwards monitoring platform, meaning staff would primarily learn new parameters and interpretation within a familiar interface. Rhythm360, while unifying diverse data, introduces a new platform for data aggregation and alert management, which may require training on its specific UI and workflow for managing various cardiac device outputs.
While Acumen HPI is backed by Edwards Lifesciences, Rhythm360 explicitly offers optional 24/7/365 oversight by certified cardiac technicians (CCTs) to assist with monitoring and alert management. This additional service can significantly augment clinic staff capacity and ensure continuous expert review of cardiac data.
Acumen HPI focuses on real-time clinical decision support within acute care, with data typically integrated into the patient's monitoring record. Rhythm360 offers robust administrative features including automated CPT code documentation and billing, which streamlines revenue cycle management and provides a clear audit trail for remote monitoring services.
AI Tool Finder
AI-powered search. Results may not be comprehensive.